US Patent Issued to DAIICHI SANKYO on July 8 for "Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate" (Japanese Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,344, issued on July 8, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate" was invented by Narihiro Toda (Tokyo), Yusuke Ota (Tokyo), Fuminao Doi (Tokyo), Masaki Meguro (Tokyo), Ichiro Hayakawa (Tokyo), Shinji Ashida (Tokyo), Takeshi Masuda (Tokyo), Takashi Nakada (Tokyo), Mitsuhiro Iwamoto (Tokyo), Naoya Harada (Tokyo), Tomoko Terauchi (Tokyo), Daisuke Okajima (Tokyo), Kensuke Nakamura (Tokyo), Hiroaki Uchida (Tokyo) and Hirofumi Hamada (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a ...